Sodertalje, Sweden

Yvonne Lo-Alfredsson

USPTO Granted Patents = 3 



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Södertälje, SE (2014)
  • Sodertalje, SE (2010 - 2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yvonne Lo-Alfredsson: Innovator in Therapeutic Compounds

Introduction

Yvonne Lo-Alfredsson is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. Her work focuses on developing novel compounds that have the potential to treat various medical conditions.

Latest Patents

Among her latest patents are the Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy. These patents disclose novel compounds of formula (I), wherein R, R, L, X, and Y are defined in the specification, along with pharmaceutically acceptable salts. The compounds are recognized as inhibitors of the enzyme MPO, making them particularly useful in the treatment or prophylaxis of neuroinflammatory disorders, cardiovascular disorders, and respiratory disorders.

Career Highlights

Yvonne Lo-Alfredsson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to focus on innovative solutions in the healthcare sector, contributing to advancements in therapeutic treatments.

Collaborations

Yvonne has collaborated with notable colleagues, including Donald Pivonka and Anders Bogevig. These partnerships have enhanced her research and development efforts, leading to impactful innovations in her field.

Conclusion

Yvonne Lo-Alfredsson's contributions to the development of therapeutic compounds highlight her role as a key innovator in the pharmaceutical industry. Her patents reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…